Your browser doesn't support javascript.
loading
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
Ibragimova, Khava I E; Geurts, Sandra M E; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; Teeuwen-Dedroog, Nathalie J A; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G.
Affiliation
  • Ibragimova KIE; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands.
  • Geurts SME; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands.
  • Meegdes M; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands.
  • Erdkamp F; Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
  • Heijns JB; Department of Medical Oncology, Amphia, Breda, the Netherlands.
  • Tol J; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, the Netherlands.
  • Vriens BEPJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands.
  • Dercksen MW; Department of Medical Oncology, Máxima Medical Center, Eindhoven, the Netherlands.
  • Aaldering KNA; Department of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands.
  • Pepels MJAE; Department of Internal Medicine, Elkerliek Hospital, Helmond, the Netherlands.
  • van de Winkel L; Department of Internal Medicine, St Anna Hospital, Geldrop, the Netherlands.
  • Peters NAJB; Department of Internal Medicine, Sint Jans Gasthuis Hospital, Weert, the Netherlands.
  • Teeuwen-Dedroog NJA; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands.
  • Vriens IJH; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands.
  • Tjan-Heijnen VCG; Department of Medical Oncology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, PO BOX 5800, 6202 AZ, Maastricht, the Netherlands. vcg.tjan.heijnen@mumc.nl.
Breast Cancer Res Treat ; 198(2): 239-251, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36635428
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Type: Article Affiliation country: Netherlands